Companies
Mangoceuticals Inc [MGRX] Revenue clocked in at $0.50 million, down -27.77% YTD: What’s Next?
Mangoceuticals Inc [NASDAQ: MGRX] price surged by 4.17 percent to reach at $0.01. The company report on March 12, 2024 at 9:00 AM that MangoRx Officially Launches ‘PRIME’ by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment. The Dallas Based, Direct-to-Consumer
